MedPath

Assessment of the best absorption of levothyroxine liquid formulation in conjunction with the intake of food

Conditions
Hypothyrodism
Therapeutic area: Diseases [C] - Hormonal diseases [C19]
Registration Number
EUCTR2013-001696-21-IT
Lead Sponsor
AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

_ Males and females of all races, with age from 18 to 75 years old.
2_ Patients that are able to participate in the study, who have given their writing informed consent .
3_ Patients with acquired hypothyroidism

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 80
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20

Exclusion Criteria

1_Ischemic heart disease, unstable arrhythmias, uncontrolled hypertension, congestive heart failure (NYHA III and IV).
2_Unstable or uncontrolled diabetes mellitus.
3_ Untreated hypercholesterolemia
4_Women of childbearing age who wish to offspring

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To assess if the thyroid hormones (TSH, fT4 and fT3) of hypothyroid patients in therapy with L-T4 oral solution (Tirosint ®) are alterated by concomitant intake of food.;Secondary Objective: Not applicable;Primary end point(s): To assess if the thyroid hormones (TSH, fT4 and fT3) of hypothyroid patients in therapy with L- <br> T4 oral solution (Tirosint ®) are alterated by concomitant intake of food.<br>;Timepoint(s) of evaluation of this end point: At recruitment, at 40 days, and possibly at 80 or 120 days after the beginning of therapy with L-thyroxine oral solution (Tirosint ®)
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): not applicable;Timepoint(s) of evaluation of this end point: not applicable
© Copyright 2025. All Rights Reserved by MedPath